Are GRIK3 (T928G) gene variants in schizophrenia patients different from those intheir first-degree relatives?

Psychiatry Research

Volumn 175, Issue 1-2, 2010, Pages 43-46

  Kilic, Gamze ^a   Ismail Kucukali, Cem ^b   Orhan, Nurcan ^c   Ozkok, Elif ^c   Zengin, Asli ^c   Aydin, Makbule ^c   Kara, Ihsan ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Istanbul Erenkoy Psychiatric and Neurological Disorders Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

AMPA receptor; GRIK3; Kainate receptor; Polymorphism; Relatives; Schizophrenia

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR GRIK3; GUANINE; THYMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA;

ADULT; FAMILY; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, KAINIC ACID; REGRESSION ANALYSIS; SCHIZOPHRENIA;

EID: 72049119606     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.10.001     Document Type: Article

References (28)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 4th ed. APA, (1994), American Psychiatric Press, Washington, DC
2. Andreasen N.C. Methods for assessing positive and negative symptoms. Modern Problems of Pharmacopsychiatry 24 (1990) 73-88
3. Begni S., Popoli M., Moracsi S., Bignotti S., Tura G.B., and Generalli M. Association between the ionotropic glutamate receptor kainate 3 (GRIK3) ser 310 Ala polymorphism and schizophrenia. Molecular Psychiatry 7 (2002) 416-418
4. Benes F.M., Todtenkopf M.S., and Kostoulakos P. Glu R5, 6, 7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus 11 (2001) 482-491
5. Chouinard G., Roo-Chouinard A., Annable L., and Jones B. Extrapyramidal Symptom Rating Scale. The Canadian Journal of Neurological Sciences 7 (1980) 234
6. Deakin J.F., Slater P., Simpson M.D.C., Gilchrist A.C., Skan A.C., Royston M.C., Reynolds G.P., and Cross A.J. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. Journal of Neurochemistry 52 (1989) 1781-1786
7. DeLisi L.E., Mesen A., Rodriguez C., Bertheau A., Laprade B., Llach M., Riondet S., Razi K., Relja M., Byerley W., and Sherrington R. Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. American Journal of Medical Genetics 114 (2002) 497-508
8. Endicott J., and Spitzer R.L. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry 35 (1978) 837-844
9. First M.B., Spitzer R.L., and Williams J.B.W. Structured Clinical Interview for DSM-IV (SCID) (1997), American Psychiatric Association, Washington, DC
10. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. The American Journal of Psychiatry 158 (2001) 1367-1377
11. Kretschmer B.D., Goiny M., and Herrera-Marschitz M. Effect of intracerebral administration of NMDA and AMPA on dopamine and glutamate release in the ventral pallidum and on motor behavior. Journal of Neurochemistry 74 (2000) 2049-2057
12. Lai I.C., Liou Y.J., Chen J.Y., and Wang Y.C. No association between the ionotropic glutamate receptor kainate 3 gene ser310ala polymorphism and schizophrenia. Neuropsychobiology 51 (2005) 211-213
13. Magaro P.A., Abrams L., and Cantrell P. Maine Scale of Paranoid and Nonparanoid Schizophrenia: reliability and validity. Journal of Consulting and Clinical Psychology 49 (1981) 438-447
14. Meador-Woodruff J.H., Davis K.L., and Haroutunian V. Abnormal Kainate receptor expression in prefrontal cortex in schizophrenia. Neuropsychopharmacology 24 (2001) 545-552
15. Meador-Woodruff J.H., and Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Research Reviews 31 (2000) 288-294
16. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 (1988) 1215
17. Nutt S.L., Hoo K.H., Rampersad V., Deverill R.M., Elliott C.E., Fletcher E.J., Adams S.L., Korczak B., Foldes R.L., and Kamboj R.K. Molecular characterization of the human EAA5 (GluR7) receptor: a high-affinity kainate receptor with novel potential RNA editing sites. Receptors Channels 2 (1994) 315-326
18. Nishikawa T., Takashima M., and Toru M. Increased [3H] kainic acid binding in the prefrontal cortex in schizophrenia. Neuroscience Letters 40 (1983) 245-250
19. Overall J.E., and Gorham D.R. The Brief Psychiatric Rating Scale. Psychological Reports 10 (1962) 799-812
20. Rhinewine J.P., Lencz T., Thaden E.P., Cervellione K.L., Burdick K.E., Henderson I., Bhaskar S., Keehlisen L., Kane J., Kohn N., Fisch G.S., Bilder R.M., and Kurma S. Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates. Biological Psychiatry 58 (2005) 705-712
21. Riley B., and Kendler K.S. Molecular genetic studies of schizophrenia. European Journal of Human Genetic 14 (2006) 669-680
22. Schiffer H.H., Swanson G.T., Masliah E., and Heinemann F. Unequal expression of allelic kainate receptor GluR7 mRNAs in human brains. The Journal of Neuroscience 20 (2000) 9025-9033
23. Samochowiec J., Grzywacz A., Kucharska-Mazur J., Samochowiec A., Horodnicki J., Pelka-Wysiecka J., and Syrek S. Family-based and case-control association studies of glutamate receptor GRIK3 Ser310Ala polymorphism in Polish patients and families with alcohol dependence. Neuroscience Letters 396 (2006) 159-162
24. Shibata H., Shibata A., Ninomiya H., Tashiro N., and Fukumaki Y. Association study of polymorphisms in the GluR6 kainate receptor gene (GRIK2) with schizophrenia. Psychiatry Research 113 (2002) 59-67
25. Shibata H., Aramaki T., Sakai M., Ninomiya H., Tashiro N., Iwata N., Ozaki N., and Fukumaki Y. Association study of polymorphisms in the GluR7, KA1 and KA2 kainate receptor genes (GRIK3, GRIK4, GRIK5) with schizophrenia. Psychiatry Research 141 (2006) 39-51
26. Sokolov B.P. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics. Journal of Neurochemistry 71 (1998) 2454-2464
27. Stip E., Chouinard S., and Boulay L.J. On the trail of a cognitive enhancer for the treatment of schizophrenia. Progress in Neuro-psychopharmacology and Biological Psychiatry 29 (2005) 219-232
28. Svensson T.H. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Research Reviews 31 (2000) 320-329